Bionano Genomics Announces “At-The-Market” Equity Program
SAN DIEGO, Aug. 17, 2020 (GLOBE NEWSWIRE) — Bionano Genomics, Inc. (Nasdaq: BNGO) announced today that it has filed a […]
GWG Holdings, Inc. Reports Results for the Second Quarter Ended June 30, 2020
DALLAS, Aug. 17, 2020 (GLOBE NEWSWIRE) — Today, GWG Holdings, Inc. (Nasdaq: GWGH), an innovative financial services firm based in […]
Odyssey Marine Exploration Reports Second Quarter 2020 Results
TAMPA, Fla., Aug. 17, 2020 (GLOBE NEWSWIRE) — Odyssey Marine Exploration, Inc. (NASDAQ:OMEX), a deep-ocean exploration pioneer engaged in the […]
Entera Bio to Report Second Quarter 2020 Business and Financial Results on August 20, 2020
BOSTON and JERUSALEM, Aug. 17, 2020 (GLOBE NEWSWIRE) — Entera Bio Ltd. (NASDAQ: ENTX), a leader in the development of […]
Flushing Financial Corporation and Empire Bancorp Inc. Agree to Complete Their Merger Under Extended Time Frame
UNIONDALE and ISLANDIA, N.Y., Aug. 17, 2020 (GLOBE NEWSWIRE) — Today, John R. Buran, President and Chief Executive Officer of […]
XBiotech Discovers COVID-19 Candidate Therapy
AUSTIN, Texas, Aug. 17, 2020 (GLOBE NEWSWIRE) — XBiotech Inc. (NASDAQ: XBIT) announced today that it has identified True Human […]
TRACON Pharmaceuticals Announces FDA Clearance of ENVASARC Pivotal Trial
SAN DIEGO, Aug. 17, 2020 (GLOBE NEWSWIRE) — TRACON Pharmaceuticals (NASDAQ:TCON), a clinical stage biopharmaceutical company focused on the development […]
Organovo Announces One-for-Twenty Reverse Stock Split
SAN DIEGO, Aug. 17, 2020 (GLOBE NEWSWIRE) — Organovo Holdings, Inc. (the “Company”) (Nasdaq: ONVO) today announced that it filed […]
Lamar Advertising Company Announces Proposed Private Offering of an Additional $150 Million of 4% Senior Notes due 2030
BATON ROUGE, La., Aug. 17, 2020 (GLOBE NEWSWIRE) — Lamar Advertising Company (Nasdaq: LAMR) announced today that it is seeking […]
Checkpoint Therapeutics to Present at Virtual Corporate Access Summit Hosted by B. Riley FBR on Wednesday, August 19, 2020
NEW YORK, Aug. 17, 2020 (GLOBE NEWSWIRE) — Checkpoint Therapeutics, Inc. (“Checkpoint”) (NASDAQ: CKPT), a clinical-stage immunotherapy and targeted oncology […]
